Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Anemia In Elderly Market from 2024 to 2025?

The market for anemia in the elderly has witnessed a robust growth in the preceding years. The market size is predicted to expand from $2.75 billion in 2024 to $3.02 billion in 2025, displaying a compound annual growth rate (CAGR) of 9.7%. The notable growth in the past years is due to factors such as dietary insufficiencies, persistent illnesses, inflammation, disorders of the bone marrow, and blood loss.

What Is the Projected Market Size of the Anemia In Elderly Market?

Expectations are in place for the anemia in elderly market to experience substantial expansion in the coming years. Forecasts predict an increase to $4.32 billion in 2029, with a compound annual growth rate (CAGR) of 9.3%. The anticipated growth within this time frame is due to factors such as the increasing elderly population, the escalation of chronic disease prevalence, enhancement in diagnostic technology, a rise in healthcare knowledge, and broader access to treatment options. Crucial trends for the forecast period involve diagnostics powered by AI, health monitors that are wearable, highly developed tools for blood analysis, the inclusion of telehealth, and solutions centered around personalized medicine.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20711&type=smp

Who are the Major Competitors in the Anemia In Elderly Market Outlook?

Major companies operating in the anemia in elderly market are Johnson & Johnson, Roche Holding AG, Merck & Co Inc, Bristol-Myers Squibb Company, AstraZeneca plc, Novartis International AG, Takeda Pharmaceutical Company Limited, Amgen Inc, Japan Tobacco Inc, Fresenius Medical Care AG, Teva Pharmaceutical Industries Ltd, Sandoz International GmbH, CSL Limted, Daiichi Sankyo Company Limited, Amag Pharmaceuticals, Akebia Therapeutics Inc, Pharmacosmos A/S, Rockwell Medical Inc, Bioage Labs Inc, Shield Therapeutics Plc, MegaPro Biomedical Co Ltd

What Is Fueling Growth in the Anemia In Elderly Market?

The continual increase in elderly populace is anticipated to boost the expansion of the anemia in the elderly market in the future. The senior citizen demographic, defined as those aged 65 or older, is growing proportionally in many societies and globally. The rise in elderly numbers can be attributed to factors such as improved longevity, declining birth rates, and the aging of larger population groups. This surge in elderly populace leads to higher incidences of age-related and chronic diseases, major contributors to anemia in senior individuals. This, in turn, increases the need for anemia diagnosis, management, and treatment thus promoting market development. For example, data from the Office for National Statistics (ONS), a UK governmental body, shows that as of July 2024, the count of individuals aged 65 and above in the UK surged to 12.7 million in 2022 from 11 million in 2021. Therefore, this rise in the elderly population is a significant factor in the expansion of the anemia in the elderly market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=20711&type=smp

Which Anemia In Elderly Market Segments Are Growing the Fastest?

The anemia in elderly market covered in this report is segmented –

1) By Product Type: Tablets, Injectable

2) By Treatment: Iron Supplements, Erythropoietin Or Erythrocyte-Stimulating Agents, Vitamin B12 Supplements, Folic Acid Supplements

3) By Route Of Administration: Oral, Parenteral

4) By End User: Hospital pharmacy, Online Pharmacy, Retail pharmacy

Subsegments:

1) By Tablets: Iron Supplements, Vitamin B12 Supplements, Folic Acid Tablets, Erythropoiesis-Stimulating Agents (ESAs) Tablets

2) By Injectable: Iron Injections, Vitamin B12 Injections, Erythropoiesis-Stimulating Agents (ESAs) Injections, Folic Acid Injections

Which Industry Trends Are Shaping the Future of the Anemia In Elderly Market?

Leading firms in the anemia in the elderly market are concentrating on technological innovations, such as customized treatments, in effort to enhance treatment procedures, improve the health outcomes of patients, minimize side effects and boost overall medical efficiency. Personalized treatments are healthcare services tailored to the unique features of each patient. For example, Cadila Pharmaceuticals, a company from India, unveiled the Redshot FCM in March 2024. This innovative iron injection, designed for treating iron deficiency anemia in patients who have difficulty tolerating oral iron, is an example of intravenous iron preparation capable of providing sufficient iron quantities while maintaining an outstanding safety profile. The formulation combines Ferric Carboxymaltose, which enhances iron delivery and absorption. Redshot FCM illustrates Cadila’s commitment to enhancing healthcare via developing customized treatments that consider individual patient characteristics, leading to improved treatment results for iron deficiency anemia.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/anemia-in-elderly-global-market-report

Which Countries Are Leading the Anemia In Elderly Market?

North America was the largest region in the anemia in elderly market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anemia in elderly market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20711

This Report Delivers Insight On:

1. How big is the anemia in elderly market, and how is it changing globally?

2. Who are the major companies in the anemia in elderly market, and how are they performing?

3. What are the key opportunities and risks in the anemia in elderly market right now?

4. Which products or customer segments are growing the most in the anemia in elderly market?

5. What factors are helping or slowing down the growth of the anemia in elderly market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model